Covivio Office AG

  • Land: Deutschland

Nachricht vom 07.05.2020 | 14:28

Godewind Immobilien AG: Great approval at the annual general meeting and changes in the management team

DGAP-News: Godewind Immobilien AG / Key word(s): AGM/EGM/Personnel
07.05.2020 / 14:28
The issuer is solely responsible for the content of this announcement.

Godewind Immobilien AG: Great approval at the annual general meeting and changes in the management team

Frankfurt am Main, 7 May 2020 -
At today's ordinary virtual Annual General Meeting 2020 of Godewind Immobilien AG (ISIN: DE000A2G8XX3, trading symbol: GWD, Godewind), the shareholders approved all agenda items with a large majority. The presence of the share capital was 31.41% or, taking into account votes cast by postal vote, 77.06%.

The items on the agenda included the resolution on the appropriation of net profit for 2019, the discharge of the members of the Executive Board and Supervisory Board and the appointment of the auditor for the 2020 financial year. Under agenda item 8, a resolution was passed to change the company name to "Covivio Office AG" in connection with the voluntary takeover and delisting offer.

With effect from the end of the Annual General Meeting, the Supervisory Board members Dr. Bertrand Malmendier and Dr. Roland Folz resigned their positions. The Annual General Meeting appointed Dr. Uwe Becker and Rainer Langenhorst to the Supervisory Board with a large majority. At the subsequent constitutive meeting of the Supervisory Board, Dr. Uwe Becker was elected Chairman and Rainer Langenhorst was elected Deputy Chairman.

After the conclusion of the Annual General Meeting, the members of the Godewind Immobilien AG Executive Board, Stavros Efremidis and Ralf Struckmeyer, resigned their Executive Board mandates with immediate effect and by agreement with the Supervisory Board. The Supervisory Board has appointed Marcus Bartenstein and Dr. Daniel Frey as new members of the Executive Board, who as Co-CEOs will drive forward the further development of Godewind Immobilien AG under the holding of the Covivio Group.

About Godewind Immobilien AG
Godewind Immobilien AG, headquartered in Frankfurt am Main, is a company specialising in German office real estate. The company focuses on building and extending an attractive real estate portfolio in the growth areas of Germany. As an active portfolio and asset manager, Godewind strives for sustainable increases in earnings and income, which are supplemented by the regular realisation of added value potential. Godewind currently has an office property portfolio of around 1.1 billion euros. In the medium term, the aim is to build a commercial real estate portfolio of around three billion euros with the help of the company's wide-ranging network and by means of value-added acquisitions.

Based on internal portfolio and asset management, Godewind Immobilien AG will manage commercial real estate cost-efficiently, conclude long-term rental agreements and thus increase the value of the company. The company has loss carryforwards for corporation and trade tax purposes and a tax deposit account. The Godewind Immobilien AG shares are listed in the SDAX and in the highest transparency level of Deutsche Börse AG, Prime Standard, and are traded in the XETRA market segment of the Frankfurt Stock Exchange (FWB), among others.

For further information please visit

Contact Details

Investor Relations Contact

Gunnar Janssen
Godewind Immobilien AG
Phone +49 69 27 13 97 32 13

Press Contact
Jan Hutterer
Kirchhoff Consult AG
Phone +49 40 60 91 86 65

07.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021